- Supported exchanges /
- KQ /
- 241820.KQ
PCL Inc (241820 KQ) stock market data APIs
PCL, Inc. provides multiplex in vitro diagnostic (IVD) products and platform services. The company offers HiSU solution, an automated multi-immune diagnostic system that performs various diagnostics, high-speed tests including blood screening, multiple cancer screening, autoimmune testing, etc. It also provides antigen and antibody diagnostic kits, including PCLOK II anti-HIV/HCV/syphilis, and PCLOK II HBsAg/HIV p24. In addition, the company offers platform services, such as SG ID for identifying novel target substances. Further, it offers covid-19 solutions, such as PCLMD nCoV one step RT-PCR, PCL COVID19 speed RTPCR, PCLMD ABC multi RTPCR molecular diagnostic kits; PCL COVID19 Ag rapid FIA, and PCL COVID19 Ag gold antigen diagnostic kits; and PCL COVID19 IgG/IgM rapid gold, and PCL COVID19 total Ab EIA antibody diagnostic kits. PCL, Inc. was incorporated in 2008 and is headquartered in Seoul, South Korea.
PCL Inc Financial Data Overview
| 697 | |
| 677 | |
| - | |
| 715 | |
| 668 | |
| 666-4385 | |
| 41 539 M | |
| 59 172 K | |
| 7 830 M | |
| -57.2682 | |
| 0.061 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
PCL Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 7 830 M
- EBITDA -12 340 179 968
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get PCL Inc Earnings via APIs
- Latest Release 2024-06-30
- EPS/Forecast NaN
Get PCL Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
